Systemic autoimmune diseases and autoinflammatory syndromes comprise a broad range of conditions characterized by dysregulation of the immune system, giving rise to activation of immune cells, inappropriate inflammation and multiorgan damage. They represent a poorly understood group of conditions that in many cases disproportionately affect women and minorities and have a very significant impact in morbidity and mortality. The pathogenesis of this heterogenous group of diseases remains incompletely characterized and there are no existing cures. Therefore, individuals affected by these diseases require long-term treatment, making systemic autoimmune diseases be a mounting public health concern across the world. 

As such, this meeting will focus of reviewing novel areas pertaining to the understanding of key immune mechanisms that may play important pathogenic roles in the initiation, perpetuation and development of organ damage in systemic autoimmune diseases and autoinflammatory syndromes.  In addition, the program will cover  key aspects of diagnosis and treatment of these conditions, taking into consideration the development of important technological advances in the study of this diseases at the bench with critical implications for translational approaches.

The meeting will address novel areas of knowledge in the understanding of the pathophysiology of systemic autoimmune diseases and novel discoveries in autoinflammatory diseases that have emerged recently. We will bring together a diverse and interdisciplinary group of scientists from academia, government and industry, young and senior investigators to interact and exchange ideas on novel aspects of immunology, molecular biology, bioinformatics, and medicine.